Caseware UK (AP4) 2024.0.164 2024.0.164 Caseware UK (AP4) 2024.0.164 2024.0.164 2025-02-28 1376 55166 84813 1032 54456 55488 1032 1376 false 2024-03-01 No description of principal activity 1 1 2025-02-28 7957558 2024-03-01 2025-02-28 7957558 2023-03-01 2024-02-29 7957558 2025-02-28 7957558 2024-02-29 7957558 2024-03-01 7957558 2023-03-01 7957558 c:RegisteredOffice 2024-03-01 2025-02-28 7957558 d:OfficeEquipment 2024-03-01 2025-02-28 7957558 d:OfficeEquipment 2025-02-28 7957558 d:OfficeEquipment 2024-02-29 7957558 d:CurrentFinancialInstruments 2025-02-28 7957558 d:CurrentFinancialInstruments 2024-02-29 7957558 c:FRS102 2024-03-01 2025-02-28 7957558 c:IndependentExaminationCharity 2024-03-01 2025-02-28 7957558 c:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 7957558 b:Trustee1 2024-03-01 2025-02-28 7957558 b:Trustee6 2024-03-01 2025-02-28 7957558 b:Trustee7 2024-03-01 2025-02-28 7957558 b:Trustee8 2024-03-01 2025-02-28 7957558 b:Trustee9 2024-03-01 2025-02-28 7957558 b:RestrictedIncomeFunds 2024-03-01 2025-02-28 7957558 b:RestrictedIncomeFunds 2023-03-01 2024-02-29 7957558 b:TotalEndowmentFunds 2024-03-01 2025-02-28 7957558 b:TotalEndowmentFunds 2023-03-01 2024-02-29 7957558 b:RestrictedIncomeFunds 2025-02-28 7957558 b:RestrictedIncomeFunds 2024-02-29 7957558 b:TotalEndowmentFunds 2025-02-28 7957558 b:TotalEndowmentFunds 2024-02-29 7957558 b:TotalUnrestrictedFunds 2025-02-28 7957558 b:TotalUnrestrictedFunds 2024-02-29 7957558 b:TotalRestrictedIncomeFunds 2025-02-28 7957558 b:TotalRestrictedIncomeFunds 2024-02-29 7957558 c:FullAccounts 2024-03-01 2025-02-28 xbrli:pure iso4217:GBP

Registered number: 7957558 Charity number: 1148789 UKPIPS (A company limited by guarantee) UNAUDITED TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
UKPIPS (A company limited by guarantee) CONTENTS
| Page
Reference and administrative details of the company, its Trustees and advisers | 1
Trustees' report | 2 - 7
Independent examiner's report | 8
Statement of financial activities | 9
Balance sheet | 10 - 11
Notes to the financial statements | 12 - 23
UKPIPS (A company limited by guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 28 FEBRUARY 2025
Trustees | Susan Jane Dimmock, Chair (appointed 10 March 2023)
| Gary Narborough, Trustee (appointed 1 April 2023)
| David Cohen, Trustee (appointed 1 April 2023)
| Judith Gower, Trustee (appointed 24 February 2024)
| Andrew Morris, Trustee (appointed 24 February 2024)
Company registered number | 7957558
Charity registered number | 1148789
Registered office | Marine House 151 Western Road Haywards Heath, RH16 3LH
Accountants | GMBC LLP Chartered Tax Advisers and Accountants Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH
Scottish charity registered number | SC044636
Page 1
UKPIPS (A company limited by guarantee) TRUSTEES' REPORT FOR THE YEAR ENDED 28 FEBRUARY 2025 The Trustees present their annual report together with the financial statements of UKPIPS for the 1 March 2024 to 28 February 2025. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019). Since the company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted. Objectives and activities a. Policies and objectives The charity’s objectives are: • To provide information and support for patients (and their carers, partners and family) with a Primary Antibody Deficiency (PAD) and other Primary Immune Deficiencies (PID), residing permanently or temporarily in the United Kingdom • To establish a volunteer medical panel comprising appropriate experts • To advance the education of the general public and medical community in all areas relating to a Primary Antibody Deficiency and other Primary Immune Deficiencies • To promote the social and medical welfare of people with a Primary Antibody Deficiency and other Primary Immune Deficiencies • To encourage research into Primary Antibody Deficiency and other Primary Immune Deficiencies • To champion recognition and representation • To expand activities from time to time in any way that may be consistent with the foregoing to bring benefit to the community of people in the UK with a Primary Antibody Deficiency and other Primary Immune Deficiencies In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'. The aims of our charity are to provide anyone with a Primary Immune Deficiency or a Primary Antibody Deficiency, their carers and friends a place where they can find advice and support. Page 2
UKPIPS (A company limited by guarantee) Objectives and activities (continued) b. Activities undertaken to achieve objectives Each year the trustees review UKPIPS’ aims and objectives and activities, and the achievements in the previous 12 months. Our priorities for the year were identified as: • To recruit further volunteers so that there is a continuing pool of knowledge and expertise underpinning the charity and its functions, allowing for succession planning. •To develop a business plan for the charity that aligns to trustee skills and capabilities. •To formalise policies that meet the needs of the charity and the Charities Commission. •To review the Memorandum and Articles of Association and decide if there is a better operating model for the charity. •To review the charity’s financial model and generate charity income from new sources to remain viable. Achievements and performance a. Review of activities Following the recruitment of our two new Trustees in February 2024, Judith Gower and Andrew Morris have been adjusting into their new roles and supporting the other three Trustees to develop and review the existing Business Plan, Risk Register and various outstanding obligatory policies. As part of the review of the Business Plan a series of objectives were developed for 2024/5 (outlined above) and the following Trustee roles were agreed: ∙Business Management including oversight of Volunteers and Medical Panel (Sue Dimmock, David Cohen and Gary Narborough) ∙Legal and Governance (Judith Gower and Treasurer) ∙IT (David Cohen and IT Support) ∙Financial Resources (all Trustees and Treasurer) ∙Operations – including NHS, Medical Board and pharmaceuticals (Sue Dimmock and David Cohen) ∙Communications, Marketing and Public Relations, including performance management and aspects of the interface between members and the charity (Andrew Morris, David Cohen and Sue Dimmock) ∙Advocacy and safeguarding (Gary Narborough and Judith Gower) Both Judith and Andrew completed their DBS checks and attended recommended training for new Trustees with the Charities Commission. Our thanks go to Carolyn Middleton for her unwavering support to UKPIPS in her administrative role; to Dave McNally for his dedication to our finances and reporting requirements, and to Nigel Goode for his excellent maintenance of the UKPIPS IT estate and website. Thanks also go to Meg Fuller for all her help on the policy work. During the year the following activities are worthy of note: ∙A letter was sent to government in March 2024, along with other charities (eg Forgotten 500k) on the date of the fourth anniversary of COVID lockdown. The letter highlighted the ongoing issues faced by immunocompromised people including ongoing shielding; mental health impacts; the affect on the economy of having a section of the community who are still not completely reintegrated into daily living. It also strongly urged the need for prophylactic treatments to be made available to the immunocompromised as the only way to give surety of protection from the virus. ∙In March, the availability of COVID testing changed from online request and home posting to collection from community pharmacy. This required a level of communication to our community and support for people who were finding the new process difficult to follow, primarily because of the journey lengths or being housebound. UKPIPS requested that NHSE consider extending home posting and also promoted community pharmacy delivery, where available. ∙UKPIPS supported Rare Disease Day 2024 through its involvement in the planning process, co-ordinated by Genetic Alliance UK. Page 3
UKPIPS (A company limited by guarantee) Achievements and performance (continued) ∙Sue attended Parliament in April to support the I am Number 17 Campaign with Takeda. ∙The immunoglobulin contract was renewed in December 2024 without any input from patient support charities. This, together with the dreadful communication about the anticipated changes for patients and clinicians caused a flurry of meetings with NHSE, MPSC (Medicines Procurement and Supply Chain), the Immunology and Allergy Clinical reference Group (IACRG), pharmaceuticals, clinicians and concerned patients. UKPIPS did everything it could to keep patients as informed as possible (on Facebook and by emails) but found itself completely blindsided by the fact that more than half of the patient population will need to change product, due to the non-awarded status of some long existing pharmaceuticals and specific products (pre-filled syringes) in the UK immunoglobulin marketplace. ∙The tender award for UK plasma fractionation was finally announced publicly in September when we were able to share with our community that that Octapharma had been successful. The new product would be called Gamten and would be available in the UK in early 2025. ∙Regular meetings have been held with the Quality in Primary Immunodeficiency Services (QPIDS) Lay Assessor, Jeffrey Goodwin to relay issues that face patients in their interactions with Immunology services and the NHSE services they receive. ∙Sue has been involved as part of her role in the IACRG with a review of the Immunology Service Specification, last reviewed in 2018. Working alongside senior NHS immunology clinicians the new specification (for ICBs to commission immunology services) was published in January 2025. ∙Carolyn has successfully completed another PIF TICK annual assessment and we are very grateful for all her dedication to the charity in her administrative role ∙Sue and Carolyn worked to update the UKPIPS promotional materials for a patient day at Addenbrookes in June. Judith and Sue attended the event as UKPIPS ambassadors and recruited a couple of new Facebook members as a result. ∙On the advocacy front, Gary and Sue have continued to answer any web queries received and Sue has supported one as yet undiagnosed, student who has been suffering with repeated infections and needed support to focus his university on adjusting his deadlines etc. ∙UKPIPS maintains an active interest in Homecare services through David Cohen (with the National Clinical Homecare Association) and through Sue with the NHS. ∙UKPIPS continues to provide information and support through our website; newsletters (latest published in November 2024); Facebook; LinkedIn; YouTube; weekly Zoom meetings and by mail for those who do not have access to IT. We are grateful for the support of our volunteers who help to update our social media platforms (Carol Hassard and Emma Coldray) and to Michael Howell, and Steve Harrison for their support with the Friday Zoom meetings, when Sue Dimmock is unavailable. Financial review a. Going concern After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies. b. Principal funding Our funding comes from donations from members of the UKPIPS community and support from pharmaceutical companies. Page 4
UKPIPS (A company limited by guarantee) Financial review (continued) c. Financial Review During the year our community and volunteers have continued to be vulnerable to infection and so the charity has undertaken few physical activities. Therefore, funds have been used for improving electronic means of communication, our work with other organisations, and staffing and professional fees. Other funding comes through donations from the community and legacy donations. We are extremely grateful for this generosity. Page 5
UKPIPS (A company limited by guarantee) Structure, governance and management a. Constitution UKPIPS is a charitable company limited by guarantee and was set up by a Memorandum of Association and incorporated on 21 February 2012. It is registered with the Charity Commission in England and Wales no 1148789 and with the Office of the Scottish Charity Regulator in Scotland no SC044636. b. Methods of appointment or election of Trustees The management of the company is the responsibility of the Trustees who are elected and co-opted under the terms of the Articles of Association. c. Organisational structure and decision-making policies The management of the charity is undertaken by the Trustees, acting as the management company, with support from the volunteer treasurer, administrative assistant and UKPIPS members. We are grateful to our accountants who help to ensure that we keep proper accounting records and that accounting policies are applied consistently. The administrative assistant, with support from the IT volunteer, ensures that other records are held appropriately and conform to legal requirements. All policies are agreed by the Trustees and held in the central IT system, with the supporting procedures and updates. The financial year started with only one remaining trustee following the resignation of Paul Harris. Sue Dimmock stood in as a co-opted trustee to assist Margaret Fuller. A recruitment drive was launched and two further trustees were appointed in April 2023 (David Cohen and Gary Narborough). All new trustees were formally appointed to their roles at the AGM in August 2023. The Trustees are pleased to advise that at the time of signing the Annual Report and Accounts, 5 Trustees have been co-opted to the Board. After many years of service to UKPIPS, Margaret Fuller retired at the AGM in September. UKPIPS puts on record its thanks for all her work up to this point and for all the work she continues to undertake on policies, in her volunteer voting member role. This retirement resulted in a second recruitment drive for volunteers and trustees and two further trustees were appointed at an EGM in late February 2024. UKPIPS welcomes Judith Gower and Andrew Morris to the charity as co-opted trustees, who will be formally appointed at the AGM later in 2024. Attempts were made to recruit to the Medical Panel but, despite two promising leads, no new members were available to be appointed Plans for future periods ∙Recruit a new Treasurer asap ∙Review of UKPIPS factsheets moved to next financial year ∙Review of UKPIPS Memorandum and Articles of Association, including a review of the charity structure ∙Creation of Communication Policy Members' liability The Members of the company guarantee to contribute an amount not exceeding £1 to the assets of the company in the event of winding up. Page 6
UKPIPS (A company limited by guarantee) Statement of Trustees' responsibilities The Trustees (who are also the directors of the company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to: ∙select suitable accounting policies and then apply them consistently; ∙observe the methods and principles of the Charities SORP (FRS 102); ∙make judgments and accounting estimates that are reasonable and prudent; ∙state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements; ∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Approved by order of the members of the board of Trustees and signed on their behalf by:
Susan Jane Dimmock (Chair of Trustees) |
Date: 11 September 2025 |
Page 7
UKPIPS (A company limited by guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 28 FEBRUARY 2025
Independent examiner's report to the Trustees of UKPIPS ('the company')
I report to the charity Trustees on my examination of the accounts of the company for the year ended 28 February 2025.
Responsibilities and basis of report
As the Trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. | accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or
2. | the accounts do not accord with those records; or
3. | the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
4. | the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. This report is made solely to the company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the company's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's Trustees as a body, for my work or for this report. Signed: Dated: 11 September 2025 Graham Hole GMBC LLP Chartered Tax Advisers and Accountants Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH Page 8
UKPIPS (A company limited by guarantee) STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 28 FEBRUARY 2025
|  | Restricted funds 2025 | Unrestricted funds 2025 | Total funds 2025 | Total funds 2024
| Note | £ | £ | £ | £
Income from: |  |  |  |  |
Donations and legacies | 3 | 9,036 | 1,358 | 10,394 | 8,198
Investments | 4 | - | 572 | 572 | 446
Total income |  | 9,036 | 1,930 | 10,966 | 8,644
Expenditure on: |  |  |  |  |
Charitable activities | 5 | 9,208 | 2,285 | 11,493 | 10,034
Total expenditure |  | 9,208 | 2,285 | 11,493 | 10,034
Net movement in funds |  | (172) | (355) | (527) | (1,390)
Reconciliation of funds: |  |  |  |  |
Total funds brought forward |  | 688 | 27,583 | 28,271 | 29,661
Net movement in funds |  | (172) | (355) | (527) | (1,390)
Total funds carried forward |  | 516 | 27,228 | 27,744 | 28,271
The Statement of financial activities includes all gains and losses recognised in the year.
The notes on pages 12 to 23 form part of these financial statements.
Page 9
UKPIPS (A company limited by guarantee) REGISTERED NUMBER: 7957558 BALANCE SHEET AS AT 28 FEBRUARY 2025
|  |  | 28 February |  | 29 February
|  |  | 2025 |  | 2024
| Note |  | £ |  | £
Fixed assets |  |  |  |  |
Tangible assets | 10 |  | 541 |  | 721
|  |  | 541 |  | 721
Current assets |  |  |  |  |
Cash at bank and in hand |  | 28,373 |  | 29,584 |
|  | 28,373 |  | 29,584 |
Creditors: amounts falling due within one year | 11 | (1,170) |  | (2,034) |
Net current assets |  |  | 27,203 |  | 27,550
Total assets less current liabilities |  |  | 27,744 |  | 28,271
Total net assets |  |  | 27,744 |  | 28,271
Charity funds |  |  |  |  |
Restricted funds | 13 |  | 516 |  | 688
Unrestricted funds | 13 |  | 27,228 |  | 27,583
Total funds |  |  | 27,744 |  | 28,271
Page 10
UKPIPS (A company limited by guarantee) REGISTERED NUMBER: 7957558 BALANCE SHEET (CONTINUED) AS AT 28 FEBRUARY 2025 The company was entitled to exemption from audit under section 477 of the Companies Act 2006. The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006. The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime. The financial statements were approved and authorised for issue by the Trustees on 11 September 2025 and signed on their behalf by:
Susan Jane Dimmock (Chair of Trustees) |
The notes on pages 12 to 23 form part of these financial statements.
Page 11
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
1. | General information
UKPIPS is a private charitable company, limited by guarantee, domiciled in England and Wales, registration number 7957558. The registered charity number is 1148789. The charity is also registered in Scotland and the charity number is SC044636. The registered office address is Marine House, 151 Western Road, Haywards Heath, West Sussex RH16 3LH. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. UKPIPS meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
| 2.2 | Income
All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably. Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued. Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable. Page 12
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025 2.Accounting policies (continued)
| 2.3 | Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. Expenditure is accounted for on an accruals basis and has been included under expense categories that aggregate all costs for allocation to activities. Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objectives, as well as any associated support costs. All expenditure is inclusive of irrecoverable VAT.
| 2.4 | Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
| 2.5 | Tangible fixed assets and depreciation
Tangible fixed assets costing £100 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably. Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost. Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, on a reducing balance basis. Depreciation is provided on the following basis:
|  |  |  | Office equipment | - | 25% reducing balance
| 2.6 | Cash at bank and in hand
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account. Page 13
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025 2.Accounting policies (continued)
| 2.7 | Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide. Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.
| 2.8 | Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
| 2.9 | Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the company and which have not been designated for other purposes. Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements. Investment income, gains and losses are allocated to the appropriate fund. Page 14
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
| 3. | Income from donations and legacies
|  |  | Restricted funds 2025 | Unrestricted funds 2025 | Total funds 2025 | Total funds 2024
|  |  | £ | £ | £ | £
| Grants |  |  |  |
| Takeda UK Ltd | 9,036 | - | 9,036 | -
| Subtotal detailed disclosure | 9,036 | - | 9,036 | -
| Donations | - | 1,358 | 1,358 | 8,198
| Total 2025 | 9,036 | 1,358 | 10,394 | 8,198
| Total 2024 | - | 8,198 | 8,198 |
Page 15
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
| 4. | Investment income
|  |  | Unrestricted funds 2025 | Total funds 2025 | Total funds 2024
|  |  | £ | £ | £
| Interest on cash | 572 | 572 | 446
| Total 2024 | 446 | 446 |
| 5. | Analysis of expenditure on charitable activities
|  | Summary by fund type
|  |  | Restricted funds 2025 | Unrestricted funds 2025 | Total 2025 | Total 2024
|  |  | £ | £ | £ | £
| Promote and protect sufferers of Primary Immune Deficiencies | 9,208 | 2,285 | 11,493 | 10,034
| Total 2024 | 230 | 9,804 | 10,034 |
| 6. | Analysis of expenditure by activities
|  |  | Support costs 2025 | Total funds 2025 | Total funds 2024
|  |  | £ | £ | £
| Promote and protect sufferers of Primary Immune Deficiencies | 11,493 | 11,493 | 10,034
| Total 2024 | 10,034 | 10,034 |
Page 16
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025 6.Analysis of expenditure by activities (continued)
| Analysis of support costs
|  | Promote and protect sufferers of Primary Immune Deficiencies 2025 | Total funds 2025 | Total funds 2024
|  | £ | £ | £
| Staff costs | 7,236 | 7,236 | 6,429
| Depreciation | 180 | 180 | 241
| Communication costs | 72 | 72 | 72
| Computer costs | 236 | 236 | 357
| Postage | 18 | 18 | 2
| Sundry expenses | 51 | 51 | 198
| Promotion | 1,586 | 1,586 | 14
| Insurance | 647 | 647 | 626
| Subscription | 74 | 74 | -
| Accountancy | 863 | 863 | 1,615
| Bank charges | 60 | 60 | 60
| PIF - Quality Mark Accreditation | 470 | 470 | 420
| Total 2025 | 11,493 | 11,493 | 10,034
| Total 2024 | 10,034 | 10,034 |
7. | Independent examiner's remuneration
|  |  |  | 2025 | 2024
|  |  |  | £ | £
| Fees payable to the company's independent examiner for the independent examination of the company's annual accounts | - | 720
| Fees payable to the company's independent examiner in respect of: |  |
| All other services not included above | - | 757
Page 17
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
8. | Staff costs
|  | 2025 | 2024
|  | £ | £
| Wages and salaries | 7,236 | 6,429
|  | 7,236 | 6,429
| The average number of persons employed by the company during the year was as follows:
|  | 2025 | 2024
|  | No. | No.
| Administration | 1 | 1
| No employee received remuneration amounting to more than £60,000 in either year.
9. | Trustees' remuneration and expenses
| During the year, no Trustees received any remuneration or other benefits (2024 - £NIL).
| During the year ended 28 February 2025, no Trustee expenses have been incurred (2024 - £NIL).
Page 18
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
10. | Tangible fixed assets
|  | Office equipment
|  | £
| Cost or valuation |
| At 1 March 2024 | 1,283
| At 28 February 2025 | 1,283
| Depreciation |
| At 1 March 2024 | 562
| Charge for the year | 180
| At 28 February 2025 | 742
| Net book value |
| At 28 February 2025 | 541
| At 29 February 2024 | 721
11. | Creditors: Amounts falling due within one year
|  | 28 February | 29 February
|  | 2025 | 2024
|  | £ | £
| Other taxation and social security | - | 8
| Other creditors | - | 549
| Accruals | 1,170 | 1,477
|  | 1,170 | 2,034
Page 19
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
12. | Financial instruments
|  | 28 February | 29 February
|  | 2025 | 2024
|  | £ | £
| Financial assets |  |
| Financial assets measured at amortised cost | 28,373 | 29,584
|  | 28 February | 29 February
|  | 2025 | 2024
|  | £ | £
| Financial liabilities |  |
| Financial liabilities measured at amortised cost | - | 2,034
Financial assets measured at amortised cost comprise cash at bank and in hand. Financial liabilities measured at amortised cost comprise other creditors and accruals. Page 20
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
| 13. | Statement of funds
|  | Statement of funds - current year
|  |  | Balance at 1 March 2024 £ | Income £ | Expenditure £ | Balance at 28 February 2025 £
|  | Unrestricted funds |  |  |  |
| General Funds - all funds | 27,583 | 1,930 | (2,285) | 27,228
| Restricted funds |  |  |  |
| Payroll and other overheads | - | 9,036 | (9,036) | -
| Laptops and other hardware | 688 | - | (172) | 516
|  | 688 | 9,036 | (9,208) | 516
| Total of funds | 28,271 | 10,966 | (11,493) | 27,744
Page 21
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
| 13. | Statement of funds (continued)
|  | Statement of funds - prior year
|  |  | Balance at 1 March 2023 £ | Income £ | Expenditure £ | Balance at 29 February 2024 £
|  | Unrestricted funds |  |  |  |
| General Funds - all funds | 28,743 | 8,644 | (9,804) | 27,583
| Restricted funds |  |  |  |
| Restricted Funds - all funds | 918 | - | - | 918
| Laptops and other hardware | - | - | (230) | (230)
|  | 918 | - | (230) | 688
| Total of funds | 29,661 | 8,644 | (10,034) | 28,271
Page 22
UKPIPS (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025
| 14. | Analysis of net assets between funds
|  | Analysis of net assets between funds - current year
|  |  | Restricted funds 28 February 2025 | Unrestricted funds 28 February 2025 | Total funds 28 February 2025
|  |  | £ | £ | £
| Tangible fixed assets | 516 | 25 | 541
| Current assets | - | 28,373 | 28,373
| Creditors due within one year | - | (1,170) | (1,170)
| Total | 516 | 27,228 | 27,744
|  | Analysis of net assets between funds - prior year
|  |  | Restricted funds 29 February 2024 | Unrestricted funds 29 February 2024 | Total funds 29 February 2024
|  |  | £ | £ | £
| Tangible fixed assets | (230) | 951 | 721
| Current assets | - | 29,584 | 29,584
| Creditors due within one year | - | (2,034) | (2,034)
| Other unallocated | 918 | (918) | -
| Total | 688 | 27,583 | 28,271
15. | Scottish charity registration
On 7 February 2014 UKPIPS registered as a charity under the Charities and Trustee Investment (Scotland) Act 2005. It is entered on the Scottish Charity Register under number SC044636. The charity trustees for UKPIPS are jointly responsible for running the charity and complying with Scottish charity regulations.
Page 23